US 7648701
Peptide composition as immunogen for the treatment of allergy
granted A61KA61K2039/6075A61K2039/6081
Quick answer
US patent 7648701 (Peptide composition as immunogen for the treatment of allergy) held by United Biomedical, Inc. expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Biomedical, Inc.
- Grant date
- Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/6075, A61K2039/6081, A61K38/00, A61K39/0008